MedPath

Full Spectrum vs. Standard Forward-viewing Colonoscopy

Not Applicable
Completed
Conditions
Colon Neoplasms
Interventions
Procedure: standard forward-viewing colonoscopy
Procedure: full-spectrum colonoscopy
Procedure: right colon retroflexion
Registration Number
NCT02117674
Lead Sponsor
Attikon Hospital
Brief Summary

The aim of this study is to evaluate FUSE-colonoscopy in terms of feasibility and its possible additive contribution in the detection of important lesions, namely polyps and cancers, compared to the standard "forward-viewing" approach, with and without the addition of the right-colon retroflexion technique, in a series of patients undergoing back-to-back screening or surveillance colonoscopies in a randomized fashion.

Detailed Description

We changed the anticipated number of subjects enrollment for study: NCT02117674 from 120 to 200 based on the following sample size estimation:

Tandem colonoscopies studies results, show that novel endoscopic technologies detect about 20% more adenomas than those conventional colonoscopy does (missed adenomas). Since FUSE colonoscopy cannot be considered as a perfect examination, we hypothesize that conventional colonoscopy will detect one third of the missed adenomas that FUSE detects in a similar setting. Therefore a sample size of 120 adenomas achieves 80% power to detect an odds ratio of 3.0 using a two-sided McNemar test with a significance level of 0.05. The odds ratio is equivalent to a difference between two paired proportions of 14% which occurs when the proportion of detected missed adenomas during FUSE is 21% and the proportion of missed adenomas during conventional colonoscopy is 7%. During one year period before the study initiation, our colonoscopy performance quality data show that we detect a mean number of adenomas per patient equal of 0.7 in a population similar to the one recruited in our study. Therefore, 172 patients overall will be required to detect 120 adenomas. Given the uncertainty of our estimation and in order to cope with patients exclusions, withdrawals and unexpected incomplete colonoscopies, we decided to recruit 200 patients.

A more extensive description regarding the investigators study is provided in the following fields.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
246
Inclusion Criteria
  • adults undergoing elective screening or surveillance colonoscopy
  • symptomatic adults with indication for colonoscopy
Exclusion Criteria
  • age over 80 years
  • poor overall health (ASA III, IV)
  • recent abdominal surgery
  • presence of abdominal wall hernias
  • active colitis
  • multiple right colon diverticula
  • previous bowel resection
  • inflammatory bowel disease
  • polyposis syndromes

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
standard forward-viewing colonoscopyfull-spectrum colonoscopypolyp detection with standard forward-viewing colonoscopy polyp detection in the right colon with scope retroflexion
standard forward-viewing colonoscopyright colon retroflexionpolyp detection with standard forward-viewing colonoscopy polyp detection in the right colon with scope retroflexion
standard forward-viewing colonoscopystandard forward-viewing colonoscopypolyp detection with standard forward-viewing colonoscopy polyp detection in the right colon with scope retroflexion
full-spectrum colonoscopystandard forward-viewing colonoscopypolyp detection with full-spectrum colonoscopy polyp detection in the right colon with scope retroflexion
full-spectrum colonoscopyfull-spectrum colonoscopypolyp detection with full-spectrum colonoscopy polyp detection in the right colon with scope retroflexion
full-spectrum colonoscopyright colon retroflexionpolyp detection with full-spectrum colonoscopy polyp detection in the right colon with scope retroflexion
Primary Outcome Measures
NameTimeMethod
polyp detection rateone week

per colon segment and for the entire colon

Secondary Outcome Measures
NameTimeMethod
colonoscopy completionone week

colonoscopy completion rate

procedure timeone week

intubation and withdrawal time

adverse eventsone week

adverse events rate

endoscopist's satisfactionone week

endoscopist's satisfaction quantified using a scale from 0 (not satisfied) to 10 (completely satisfied)

feasibility of the retroflexion in the right colon by traineeone week

feasibility of retroflexion in the right colon by trainee, meaning if the trainee managed to perform the right colon retroflexion or not

feasibility of retroflexion in the right colon by the consultantone week

feasibility of retroflexion in the right colon by the consultant, meaning if the consultant managed to perform the right colon retroflexion or not

patients' satisfactionone week

patients' satisfaction, quantified using a scale from 0 (not satisfied at all) to 10 (completely satisfied)

Trial Locations

Locations (2)

417 Nimts Veterans Hopsital

🇬🇷

Athens, Greece

Hepatogastroenterology Unit, 2nd Department of Internal Medicine and Research Unit, Attikon University General Hospital

🇬🇷

Athens, Greece

© Copyright 2025. All Rights Reserved by MedPath